Skip to search formSkip to main contentSkip to account menu

TNFSF9 gene

Known as: TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY, MEMBER 9, tumor necrosis factor superfamily member 9, 4-1BB-L, MOUSE, HOMOLOG OF 
National Institutes of Health

Related topics

Related topics

2 relations
CD137 antigenTNFSF8 gene

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Aberrant CD137 ligand expression induced by GATA6 overexpression promotes tumor progression in cutaneous T-cell lymphoma.
CD137 and its ligand, CD137L, are expressed on activated T cells and antigen-presenting cells, respectively. Recent studies have… 
2018
2018
CD137L dendritic cells induce potent response against cancer-associated viruses and polarize human CD8+ T cells to Tc1 phenotype
Therapeutic tumor vaccination based on dendritic cells (DC) is safe; however, its efficacy is low. Among the reasons for only a… 
2016
2016
Expression of immune checkpoints in T cells of esophageal cancer patients
Inhibition of immune checkpoint proteins (checkpoints) has become a promising anti-esophageal cancer strategy. We here tested… 
2013
2013
Analysis of CD137L and IL-17 Expression in Tumor Tissue as Prognostic Indicators for Gliblastoma
Glioblastoma multiforme (GBM) is the most common form of malignant glioma, characterized by genetic instability and unpredictable… 
2012
2012
Recurrent deletions of the TNFSF7 and TNFSF9 genes in 19p13.3 in diffuse large B‐cell and Burkitt lymphomas
A single nucleotide polymorphism‐chip analysis of 98 cases of aggressive B‐cell lymphomas revealed a recurrent deletion at 19p13… 
Highly Cited
2007
Highly Cited
2007
4-1BBL Induces TNF Receptor-Associated Factor 1-Dependent Bim Modulation in Human T Cells and Is a Critical Component in the Costimulation-Dependent Rescue of Functionally Impaired HIV-Specific CD8 T…
During chronic infection, HIV-specific CD8 T cells exhibit progressive signs of functional impairment, attributed to persistent… 
2007
2007
Targeted and Untargeted CD137L Fusion Proteins for the Immunotherapy of Experimental Solid Tumors
Introduction: CD137L is a member of the tumor necrosis factor superfamily that provides a costimulatory signal to T cells. In… 
Highly Cited
2005
Highly Cited
2005
Enhancement of HIV-Specific CD8 T Cell Responses by Dual Costimulation with CD80 and CD137L1
HIV-specific CD8 T cell responses are defective in chronic HIV infection. In this study, we report that costimulation with either… 
Highly Cited
2005
Highly Cited
2005
Evaluation of OX40 Ligand as a Costimulator of Human Antiviral Memory CD8 T Cell Responses: Comparison with B7.1 and 4-1BBL1
CTL are important effectors of antiviral immunity. Designing adjuvants that can induce strong cytotoxic T cell responses in… 
2004
2004
Murine CD8 lymphocyte expansion in vitro by artificial antigen‐presenting cells expressing CD137L (4‐1BBL) is superior to CD28, and CD137L expressed on neuroblastoma expands CD8 tumour‐reactive…
The ability to expand tumour‐infiltrating lymphocytes in vitro has been greatly enhanced by the use of antigen‐independent… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)